A carregar...
Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis
Rebound disease following cessation of disease modifying treatment (DMT) has been reported in people with both relapsing and progressive multiple sclerosis (pwRMS, pwPMS) questioning strict separation between these two phenotypes. While licensed DMT is available for pwRMS to counter rebound disease,...
Na minha lista:
| Publicado no: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5497536/ https://ncbi.nlm.nih.gov/pubmed/28695150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.410 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|